Lilly asked the FDA to step in after claiming that testing it’s done suggests copycat versions of Zepbound may carry “unknown ...

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month for a limited time.

After losing significant ground to rival Eli Lilly in the GLP-1 space over the past two years, Novo Nordisk is defending the one arena it now dominates — oral therapeutics. But with Lilly preparing to ...

A service tailored to people with workplace-based insurance coverage represents a new way for Lilly to bypass insurers and expand use of its popular obesity shot.

A previous version of this story had an incorrect title for Brian Dunkin. He is the chief medical officer of endoscopy at Boston Scientific. The story has been corrected. Millions of Americans have ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...

Nothing lasts forever, including the pounds shed in a GLP-1 program. A major study published this week finds that people who stop taking weight-loss injections regain all the weight they originally ...

NORTH CAROLINA, USA — They’re easy to access, widely promoted online, and backed by doctors. GLP-1 weight-loss injections are proven to help people shed significant weight. But as demand explodes, so ...

GLP-1 receptor agonists have gained attention as medications to manage type 2 diabetes and obesity. Drugs such as semaglutide and tirzepatide help regulate blood sugar and reduce appetite, which can ...

If you miss a dose of GLP-1, you may be able to take it right away or wait until your next scheduled dose. It depends on the medication you take and how many doses you’ve missed. Glucagon-like peptide ...

Experts warn the label is ‘more marketing than medical’; urge following evidence on nutritional recommendations for GLP-1 therapy.